Efficacy and Toxicity of CDK4/6 Inhibitors in Early and Metastatic HR+/HER2- Breast Cancer: An Updated Meta-Analysis of Phase III Trials.

Ravneet K Dhanoa, Sumin Thapa, Pragnan Kancharla, Shweta Kurian

Abstract readReview

In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ravneet K DhanoaDepartment of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, MD 21218, USA.ORCID 0009-0003-2753-984X

Sumin ThapaDepartment of Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, MD 21237, USA.ORCID 0009-0003-4093-3657

Pragnan KancharlaDepartment of Hematology/Oncology, MedStar Franklin Square Medical Center, Baltimore, MD 21237, USA.

Shweta KurianDepartment of Hematology/Oncology, MedStar Franklin Square Medical Center, Baltimore, MD 21237, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CDK4/6 inhibitorsearly breast cancerHER2-negative breast cancerhormone receptor-positive breast cancermetastatic breast cancerphase III trials

Identifiers

PMID42279298

DOI10.3390/cancers18111714

PMCPMC13255879

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.